CR20220174A - Composición farmacéutica que comprende selexipag - Google Patents

Composición farmacéutica que comprende selexipag

Info

Publication number
CR20220174A
CR20220174A CR20220174A CR20220174A CR20220174A CR 20220174 A CR20220174 A CR 20220174A CR 20220174 A CR20220174 A CR 20220174A CR 20220174 A CR20220174 A CR 20220174A CR 20220174 A CR20220174 A CR 20220174A
Authority
CR
Costa Rica
Prior art keywords
selexipag
pharmaceutical composition
diphenylpyrazin
butyloxy
isopropylamino
Prior art date
Application number
CR20220174A
Other languages
English (en)
Inventor
Alexandra Schlicker-Spain
Marc Patrik Schrader
Original Assignee
Actelion Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actelion Pharmaceuticals Ltd filed Critical Actelion Pharmaceuticals Ltd
Priority claimed from PCT/EP2020/079698 external-priority patent/WO2021078835A1/en
Publication of CR20220174A publication Critical patent/CR20220174A/es

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se relaciona con composiciones farmacéuticas que comprenden 2- {4-[N-(5,6-difenilpirazin-2-il)-N-isopropilamino]butiloxi}-N-(metilsulfonil)acetamida (selexipag, NS-304, ACT-293987) que son adecuadas para la administración oral (p.o.)
CR20220174A 2019-10-23 2020-10-22 Composición farmacéutica que comprende selexipag CR20220174A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19078905 2019-10-23
PCT/EP2020/079698 WO2021078835A1 (en) 2019-10-23 2020-10-22 Pharmaceutical composition comprising selexipag

Publications (1)

Publication Number Publication Date
CR20220174A true CR20220174A (es) 2022-05-27

Family

ID=82362361

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20220174A CR20220174A (es) 2019-10-23 2020-10-22 Composición farmacéutica que comprende selexipag

Country Status (1)

Country Link
CR (1) CR20220174A (es)

Similar Documents

Publication Publication Date Title
JOP20220093A1 (ar) تركيبة صيدلانية تشتمل على سيليكسيباغ
PH12016501310A1 (en) Pharmaceutical compositions comprising azd9291
PH12019502033A1 (en) Pharmaceutical composition comprising selexipag
CY1119817T1 (el) Στερεα μοναδα δοσολογιας διασπωμενη στο στομα που περιεχει συστατικο οιστετρολης
NO20074823L (no) Rasagilin-formuleringer med forbedret innholdsensartethet
GEP20084439B (en) Nitrogen-containing heterocyclic derivatives and pharmaceutical use thereof
MX2021004000A (es) Derivados de piperidina.
EA202092829A1 (ru) Композиции тофацитиниба с контролируемым высвобождением
NO20082547L (no) Orale formuleringer omfattende tigecycline
EP3384911A4 (en) PHARMACEUTICAL COMPOSITION CONTAINING 2- {4- [N- (5,6-DIPHENYLPYRAZIN-2-YL) -N-ISOPROPYLAMINO] BUTYLOXY} -N- (METHYLSULFONYL) ACETAMIDE
ZA202107825B (en) Pharmaceutical parenteral composition of dual glp1/2 agonist
WO2020127819A3 (en) Pharmaceutical composition comprising apixaban
EA201991287A1 (ru) Твердые фармацевтические композиции на основе тикагрелора для перорального применения
MX2021014680A (es) Derivado de benzotriazol.
WO2019194773A3 (en) The combination comprising linagliptin and metformin
MX2010001243A (es) Composicion anti-inflamatoria.
MX2021014830A (es) Conjugados de compuestos que comprenden nitrogeno heteroaromatico donador de pares de electrones pi.
MX2022007988A (es) Formas cristalinas de (s)-1-(1-acriloilpirrolidin-3-il)-3-((3,5-di metoxifenil)etinil)-5-(metilamino)-1h-pirazol-4-carboxamida.
CR20220174A (es) Composición farmacéutica que comprende selexipag
PH12017501736A1 (en) Indole derivatives
WO2020055359A3 (en) Oral dosage form of sorafenib tosylate
WO2019151965A3 (en) Solid oral pharmaceutical compositions comprising apixaban
MX2019015869A (es) Nuevas formulaciones orales de belinostat.
ZA202204907B (en) Orally disintegrating pharmaceutical compositions of apixaban
GR1008804B (el) Συνθεσεις για ιατρικη χρηση οι οποιες περιλαμβανουν υαλουρονικο οξυ ή αλατα αυτου, αμινοξεα, βιταμινες, ανοργανα αλατα και αλλα συστατικα